27 results
ARS
2024 FY
CCCC
C4 Therapeutics Inc
30 Apr 24
Annual report to shareholders
8:52am
until final data are available. Adverse differences between preliminary or interim data and final data could significantly harm our reputation … reputation and significant negative media attention; reduced resources of our management to pursue our business strategy; and the inability
ARS
5zp8ukw
28 Apr 23
Annual report to shareholders
7:03am
PRE 14A
yo8ip0lb
18 Apr 23
Preliminary proxy
7:59am
424B4
5rlgxa
21 Jun 21
Prospectus supplement with pricing info
8:08am
DRS
86knkjtl4fn6r3l6m
19 May 21
Draft registration statement
12:00am